Propanc Biopharma (PPCB) Current Assets (2011 - 2026)
Propanc Biopharma (PPCB) posted Current Assets of $8.54 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 2.3% from $8.35 million a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Current Assets (2011 - 2026) Analysis & Trends
Since fiscal Q4 2011, Propanc Biopharma has reported Current Assets for 56 quarters.
- Annual Current Assets shows a five-year compound annual growth rate of 319.2% (FY2021 to FY2026).
- In prior fiscal years, Propanc Biopharma's Current Assets was $8.35 million in FY2025, $25,441 in FY2024 (+33.6%), $19,039 in FY2023 (+26.7%) and $15,030 in FY2022 (+127.9%).
- Quarterly Current Assets has run from a low of $12,855 in fiscal Q3 2024 to a high of $9.74 million in fiscal Q3 2025 over five years.
- The strongest year-over-year quarter for Current Assets in the past five years was fiscal Q3 2022, with growth of 680.4%; the weakest was fiscal Q2 2025, with a decline of 91.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Propanc Biopharma | 595,565.74 | 595,565.74 | - | 8.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.54 Mn |
| Dec 31, 2025 | 7.71 Mn |
| Sep 30, 2025 | 8.76 Mn |
| Jun 30, 2025 | 8.35 Mn |
| Mar 31, 2025 | 9.74 Mn |
| Dec 31, 2024 | 17,984.00 |
| Sep 30, 2024 | 21,534.00 |
| Jun 30, 2024 | 25,441.00 |
| Mar 31, 2024 | 12,855.00 |
| Dec 31, 2023 | 210,824.00 |
| Sep 30, 2023 | 145,804.00 |
| Jun 30, 2023 | 19,039.00 |
| Mar 31, 2023 | 96,575.00 |
| Dec 31, 2022 | 54,226.00 |
| Sep 30, 2022 | 37,862.00 |
| Jun 30, 2022 | 15,030.00 |
| Mar 31, 2022 | 144,506.00 |
| Dec 31, 2021 | 84,878.00 |
| Sep 30, 2021 | 56,408.00 |
| Jun 30, 2021 | 6,596.00 |
API Access
Propanc Biopharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();